The market Obesity and type-2 diabetes remain expanding markets
Eldad Einav, a cardiologist and weight loss specialist, told Drugwatch
Figure 3 As a final measure, we analyzed deaths in the two groups in order to assess potential bias induced by an imbalance in these
GIP affects the ability of the body to expand its white adipose tissue storage in a healthy way allowing for increased lipid breakdown and decreased lipid spillover and ectopic fat accumulation in various organs [13]
A 2020 pharmacokinetic study published in Clinical Pharmacokinetics found that oral semaglutide reduced the Cmax of co-administered levothyroxine by approximately 33% in healthy volunteers
East Asia The High-Growth GLP-1 Nutritional Support & Wellness Hub The market for GLP-1 companion products in East Asia is expanding at a fast pace, fueled by the increasing adoption of GLP-1 agonists for weight control and diabetes treatment, increasing preference for products for easy home consumption, and the rising adoption of high-protein powders and fiber-rich digestive supplements